When was Liangyihui founded?

Liangyihui was founded in 2015 and raised its 1st funding round within a year of its incorporation.

Where is Liangyihui located?

Liangyihui is headquartered in Shanghai, China.

Who is the current CEO of Liangyihui?

Jue Wang of Liangyihui. They have also founded 1 company.

How many employees does Liangyihui have?

As of Sep 30, 2026, the latest employee count at Liangyihui is 8.

Is Liangyihui a funded company?

Liangyihui is a funded company, having raised a total of $17.1M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 2015.

When was the latest funding round of Liangyihui?

Liangyihui's latest funding was a $***** Series C round on Oct 18, 2021, with participation from 3 investors.

Where does Liangyihui rank among its competitors?

Liangyihui ranks 5th amongst 136 active competitors, of which 23 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Manta Cares, which secured $5.4M in Nov, 2025.

Who are the top competitors of Liangyihui?

Liangyihui's top competitors include OncoLens, Medshr and Curofy. Among them, Manta Cares secured the most recent funding round in November, 2025.

Liangyihui - 2026 Company Profile, Team, Funding & Competitors

Liangyihui is a series C company based in Shanghai (China), founded in 2015 by Joe Wang and Jue Wang. It operates as a Medical information platform for cancer. Liangyihui has raised $17.1M in funding from investors like Legend Capital, Detong Capital and Shunwei Capital. The company has 136 active competitors, including 23 funded and 3 that have exited. Its top competitors include companies like OncoLens, Medshr and Curofy.

Company Details

Liangyihui is an online medical information platform which focuses on the malignant tumour i.e. cancer. Mobile platform claims to provide the latest scientific authoritative information and services to oncologists and patients such as case studies, patient information, conferences and others.

Website: www.liangyihui.net
Email ID: *****@liangyihui.net
Phone Number: +86 **********

Key Metrics

Founded Year

2015

Location

Shanghai, China

Stage

Series C

Total Funding

$17.1M in 5 rounds

Latest Funding Round

Series C, Oct 18, 2021, $*****

Investors

Legend Capital & 5 more

Ranked

5^th among 136 active competitors

Employee Count

8 as on Sep 30, 2026

Investment & Acquisitions

Eckoff

Similar Companies

OncoLens & 180 more

View Liangyihui's full profile

Liangyihui has raised a total funding of $17.1M over 5 rounds. Its first funding round was on Oct 2015. Its latest funding round was a Series C round on Oct 18, 2021 for $*****. 3 investors participated in its latest round. Liangyihui has 6 institutional investors.

Here is the list of recent funding rounds of Liangyihui:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 18, 2021	7905496	Series C	4548293	9572143	7324867	9414596
Feb 16, 2021	2925055	Series C	4218034	3873242	6623240	REDHILL CAPITAL
Feb 17, 2020	9689962	Series B	2687797	2125799	6695742	1262760

Access funding benchmarks and valuations. Sign up today!

View details of Liangyihui's funding rounds and investors

The founders of Liangyihui are Joe Wang and Jue Wang. Jue Wang is the CEO of Liangyihui.

Here are the details of Liangyihui's key team members:

Joe Wang: Co-Founder of Liangyihui.
Contact Info: 1 email address
Jue Wang: Co-Founder & CEO of Liangyihui.
Contact Info: 1 email address

View details of Liangyihui's Founder profiles and Board Members

Liangyihui's employee count trend

Liangyihui has 8 employees as of Sep 26. Here is Liangyihui's employee count trend over the years:

Uncover Liangyihui's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Liangyihui include OncoLens, Medshr and Curofy. Here is the list of Top 10 competitors of Liangyihui, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OncoLens 2015, Atlanta (United States), Series B	Provider of a mobile and web-based platform for connecting oncologists	$27.1M	BIP Ventures, Atlanta Technology Angels & 4 others	48/100
2nd	Medshr 2013, London (United Kingdom), Seed	Knowledge sharing platform for Physicians	$1.89M	Founders Factory, Equinox Systems & 41 others	48/100
3rd	Curofy 2014, Gurugram (India), Acquired	Online professional network of doctors for communication and patient referrals	$1.44M	RoundGlass, India Quotient & 20 others	47/100
4th	Manta Cares 2022, San Francisco (United States), Seed	Provider of digital tools and support for cancer patients and caregivers. It offers a step-by-step digital platform to manage cancer treatment, providing guidance, explanations of treatments, and preparation for appointments. Practical tools help organize symptoms, medications, and questions. The platform also connects users with a support network offering programs for fitness, nutrition, mental health, and peer support. Informational articles on cancer-related topics are also available.	$5.4M	Sozo Ventures, Pear VC & 1 others	46/100
5th	Liangyihui 2015, Shanghai (China), Series C	Medical information platform for cancer	$17.1M	Legend Capital, Shunwei Capital & 4 others	44/100
6th	Primum 2021, New York City (United States), Seed	Network of oncologists providing peer-to-peer expert consultation. It connects oncologists with specialists in various subfields of oncology to facilitate collaboration on complex cases. The platform allows for quick access to expert opinions and guidance, improving treatment decision-making. This model aims to enhance patient care by leveraging the collective knowledge and experience within the oncology community. The network facilitates knowledge sharing and helps oncologists stay abreast of the latest advancements in the field.	-	FCA Venture Partners, North Coast Ventures	43/100
7th	Omnidoc 2018, Paris (France), Series B	Provider of social discussion platform for physicians	$9.96M	Alven, Bpifrance & 3 others	42/100
8th	WarOnCancer 2015, Stockholm (Sweden), Deadpooled	Provider of online social platform for patients subjected to cancer	$940K	-	41/100
9th	The Rounds 2012, Halifax (Canada), Series A	Provider of HIPAA and PIPEDA-compliant online network for physicians	$7.8M	Panoramic Ventures, Invest Nova Scotia & 3 others	40/100
10th	SurvivorNet 2004, New York City (United States), Series B	Provider of an online cancer prevention, treatment, information platform	$15M	Gatemore	39/100